CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
oleh: R. V. Denisova, E. I. Alexeeva, T. V. Sleptsova
| Format: | Article |
|---|---|
| Diterbitkan: | Union of pediatricians of Russia 2013-09-01 |
Deskripsi
The article presents a case of successful use of therapeutic monoclonal antibodies to interleukin 1 (canakinumab) at severe systemic juvenile idiopathic arthritis. Canakinumab treatment promptly provided reduction in clinical and laboratory disease activity indicators, increase in life quality, development of inactive disease stage and allowed avoiding prescription of glucocorticoids.